All-trans-retinoic acid (ATRA) plus oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX) versus FOLFOX alone as palliative chemotherapy in patients with advanced hepatocellular carcinoma and extrahepatic metastasis: study protocol for a randomized controlled trial

BACKGROUND: Among patients with hepatocellular carcinoma (HCC), 85% of patients have an advanced disease stage at diagnosis and curative therapies cannot be performed. Prognosis has been quite poor as until recently there was no proven effective chemotherapy. Our group found that all-trans-retinoic...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Jie, Sun, Juxian, Liu, Chang, Chai, Zongtao, Wang, Nanya, Zhang, Hui, Cheng, Shuqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489221/
https://www.ncbi.nlm.nih.gov/pubmed/31036040
http://dx.doi.org/10.1186/s13063-019-3349-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489221/
https://www.ncbi.nlm.nih.gov/pubmed/31036040
http://dx.doi.org/10.1186/s13063-019-3349-9

Ejemplares similares